Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|March 21, 2002
Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinomaJeremy R GraffClinical & Experimental Metastasis|May 14, 2003
Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAsJeremy R Graff, Stephen G ZimmerOncogene|April 20, 2004
eIF-4E expression and its role in malignancies and metastasesArrigo De Benedetti, Jeremy R GraffCell Cycle (Georgetown, Tex.)|August 23, 2008
Targeting the eIF4F translation initiation complex for cancer therapyBruce W Konicek, Chad A Dumstorf, Jeremy R GraffCancer Research|February 5, 2008
Targeting the eukaryotic translation initiation factor 4E for cancer therapyJeremy R Graff, Bruce W Konicek, Julia H Carter, et al.Molecular Cancer Therapeutics|October 26, 2010
Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosisChad A Dumstorf, Bruce W Konicek, Ann M McNulty, et al.Molecular Cancer Research : MCR|March 31, 2005
The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivationRebecca L Lynch, Bruce W Konicek, Ann M McNulty, et al.International Journal of Cancer|September 24, 2004
An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladderTaiping Chen, Chad Jackson, Ben Costello, et al.The Journal of Clinical Investigation|May 10, 2016
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancersRebecca Lock, Rachel Ingraham, Ophélia Maertens, et al.Blood|March 20, 2013
Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursorsJessica K Altman, Amy Szilard, Bruce W Konicek, et al.Pageof 3